Patent Foramen Ovale Clinical Trials
2 recruiting trials for Patent Foramen Ovale. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Patent Foramen Ovale clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by Peking University Third Hospital (1), China National Center for Cardiovascular Diseases (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Conservative treatment (drug, 1 trial), followed by Antipaletet drug, Patent Foramen Ovale Closure.
Track Patent Foramen Ovale trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Establishment of a Clinical and Prognostic Follow-up Cohort of Migraine Patients With Patent Foramen Ovale
To establish a headache center in China that combines clinical, imaging and laboratory examinations, explore the feasible treatment options for migraine combined with patent...
Internal Microstructure of Patent Foramen Ovale Related to Stroke
This study aims to (1) investigate the internal microstructure of patent foramen ovale related to cryptogenic stroke, transient ischemic attack or migraine and determine the...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Patent Foramen Ovale, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Patent Foramen Ovale, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Patent Foramen Ovale, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.